ask="4.00"
ask_size="500"
average_daily_volume="124185"
bid="2.00"
bid_size="100"
book_value="0.21"
change="+0.00"
change_from_200_day_moving_average="-0.49"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-2.08"
change_From_52_week_low="0.74"
change_in_percent="+0.00%"
close="2.39"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.54"
ebitda="-15.53M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.66"
ex_dividend_date="N/A"
float_shares="9514000"
high="2.48"
high_52_weeks="4.47"
last_trade_date="3/8/2017"
last_trade_price="2.39"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.36"
low_52_weeks="1.65"
market_capitalization="31.67M"
moving_average_200_day="2.88"
moving_average_50_day="2.46"
name="Imprimis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="5.00"
open="2.39"
pe_ratio="N/A"
peg_ratio="-0.12"
percent_change_from_200_day_moving_average="-17.02%"
percent_change_from_50_day_moving_average="-2.97%"
percent_change_from_52_week_high="-46.50%"
percent_change_from_52_week_low="+44.85%"
previous_close="2.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.17"
price_per_sales="1.79"
revenue="17.65M"
shares_outstanding="13253000"
short_ratio="5.52"
stock_exchange="NCM"
symbol="IMMY"
volume="52774"
weeks_range_52="1.65 - 4.47"
